IEG Policy is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


FDA urged to act on CBD to provide certainty for industry and consumers

Industry experts say federal action needed to address regulatory confusion and the growing state patchwork of CBD rules

This article is powered by Food Chemical News

Hemp growers and product makers are desperate for FDA to clear a path for use of CBD in foods and supplements and still see the issue as the major hurdle facing the industry, the top US lawyer for Canopy Growth said this week during a Food and Drug Law Institute (FDLI) webinar.

Related Content


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts